Stoke Therapeutics, Inc.
STOK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623526
In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Stoke Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 134 | 151 | +17 |
| Shares | 65.5M | 67.7M | +2.14M (+3.3%) |
| Value | $744.0M | $1.57B | +$830.1M (+111.6%) |
New holders (37)
Institutions that held Stoke Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (20)
Institutions that held Stoke Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| CI Private Wealth, LLC | 659,834 | $7.49M |
| Cormorant Asset Management, LP | 254,161 | $2.88M |
| State of Wisconsin Investment Board | 34,798 | $395.0K |
| Jane Street Group, LLC | 34,743 | $394.3K |
| Engineers Gate Manager LP | 33,276 | $377.7K |
| ADAR1 Capital Management, LLC | 27,285 | $309.7K |
| Squarepoint Ops LLC | 23,458 | $266.2K |
| Verition Fund Management LLC | 21,055 | $239.0K |
| Integrated Quantitative Investments LLC | 19,300 | $219.1K |
| Lazard Asset Management LLC | 13,832 | $156.0K |
| LPL Financial LLC | 12,604 | $143.1K |
| Voya Investment Management LLC | 11,283 | $128.1K |
| Aquatic Capital Management LLC | 11,099 | $126.0K |
| Profund Advisors LLC | 10,986 | $124.7K |
| Raymond James Financial Inc | 1,181 | $13.4K |
| Simplex Trading, LLC | 1,072 | $12.0K |
| Group One Trading, L.P. | 513 | $5.82K |
| Caitong International Asset Management Co., Ltd | 274 | $3.11K |
| Skopos Labs, Inc. | 69 | $784 |
| Mid-American Wealth Advisory Group, Inc. | 17 | $193 |